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Central Vein Obstruction in Vascular Access
V. Mickley*
Department of Vascular Surgery, Kreiskrankenhaus Rastatt, Engelstraße 39, D-76437, Germany
Central venous obstruction has become a major problem because of the frequent need for central venous catheters in
haemodialysis patients. This article discusses the epidemiology and clinical features of central venous obstruction and
the different surgical and interventional alternatives for its treatment.
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Central vein catheters are known tobe themain risk factor
for the development of central vein obstruction (CVO) in
haemodialysis (HD) patients. If a functioning arteriove-
nous (AV) access is created distal to such an obstruction,
massive venous hypertensionmay occur producing inca-
pacitating arm edema, ulceration and tissue loss.
Because of the steady growth of the HD population
and the persistently high percentage of late referrals
requiring emergency renal replacement therapy (RRT),
increasing numbers of HD catheters are being im-
planted. In Europe between 15% (Germany) and 50%
(UK) and in the US even 60% of end-stage renal disease
(ESRD) patients start their HD career with a catheter.1
Among prevalent ESRD patients in Europe and the
US the percentage of catheter carriers have almost dou-
bled during the last eight years.2 As a consequence, the
treatment of CVO constitutes a growing challenge to
access surgeons and interventional radiologists.
Surgical treatment of CVO is often difficult and
sometimes hazardous, but not always successful. Inter-
ventional therapy is less invasive, but it needs a dedi-
cated and experienced radiologist to achieve satisfying
Update on Renal Access and Transplantation d one of a series of
educational articles edited by Mr Christopher Gibbons, Swansea,
UK.
*Corresponding author. Dr med. Volker Mickley, Department
of Vascular Surgery, Kreiskrankenhaus Rastatt, Engelstraße 39,
D-76437 Rastatt, Germany.
E-mail address: v.mickley@klinikum-mittelbaden.de1078–5884/000439+ 06 $35.00/0  2006 Published by Elsevier Ltd.results. This article discusses the relative efficacy of
the different interventional and surgical options, with
particular respect to their long-term results.
Epidemiology and Etiology
The frequency of symptomatic CVO in the HD popu-
lation has not extensively been investigated. From
November 1999 through September 2005, the author
performed 611 primary and secondary surgical and
interventional procedures on HD access in 401 pa-
tients. Twelve interventions (2.0%) were performed
for CVO in nine patients (2.2%, [unpublished data]).
Among 640 incident HD patients, Chemla et al.3
identified 10 (1.6%) with CVO. In prevalent US and
Canadian patients much higher frequencies of CVO
(23%e29%,4,5) have been reported.
Some of these stenoses and occlusions may be
attributed to thoracic inlet syndrome,6 previous clavi-
cular fracture, extrinsic compression7,8 or pacemaker
wires.9,10 The great majority of patients presenting
with CVO, however, have a history of central vein
catheterization for HD.7
CVO is believed to be caused by chronic endothelial
trauma resulting fromminimal movements of the cath-
eter against the veinwall, possibly enhanced by throm-
bophlebitic reactions due to catheter-adherent fibrin
sheaths and biofilms. Temporary HD catheters im-
planted in the right internal jugular vein, which has
amore or less straight course to the right atrium, are as-
sociated with a lower risk of CVO than left internal
440 V. Mickleyjugular vein and subclavian vein catheters,11e20 (Table
1). Femoral vein cannulation carries a 29% risk of ilio-
femoral vein stenosis when the catheter remains in
place for longer than two weeks.21 Catheter-related
infection, and repeated or prolonged catheterization
enhance the frequency of CVO.13,19,21,22 Thus ‘‘perma-
nent’’ tunneled catheters are associated with a high in-
cidence of CVO, even when inserted through the right
internal jugular vein.23
Clinical Findings
In otherwise healthy persons, chronic central arm
vein obstruction can be compensated by numerous
collaterals along the chest wall, in the neck and in
the mediastinum. In the majority of these patients
signs and symptoms of CVO are mild or completely
absent. However, when an AV access is created pe-
ripheral to a central venous stenosis or occlusion,
the blood flow through the extremity may rise at least
four to tenfold above the resting level. In this situation
the collateral capacity may be insufficient so that
venous hypertension will develop.
Depending on the location of the obstruction and
the collateral capacity there is a wide variety of pos-
sible clinical findings. When the subclavian vein is
affected, venous collaterals will become visible around
the shoulder and the upper chest. Moderate to severe
and sometimes painful and incapacitating arm swell-
ing (Fig. 1) is the most frequent finding.24 Extreme
venous hypertension can lead to skin ulceration and
tissue loss.25,26 Acral skin changes, hyperpigmenta-
tion, pincer nail deformity and pseudo-Kaposi’s
sarcoma, have also been described.27 In more central
(brachiocephalic or superior caval) vein obstruction
unilateral face and breast swelling (Fig. 3a) may
Table 1. Frequency of central vein stenoses and occlusions follow-
ing temporary catherterization of the subclavian and the internal
jugular vein for hemodialysis
Author, year [reference] Subcl. Vein Int. Jug. Vein
# Obstruction # Obstruction
Vanherweghem, 198611 42 33%
Spinowitz, 198712 13 46%
Barrett, 198813 36 50%
Schwab, 198814 47 26%
Wanscher, 198815 53 25%
Cimochowski, 199016 32 50% 20 0%
Schillinger, 199117 50 42% 50 10%
Surratt, 199118 40 43%
Herna´ndez, 199319 54 53%
Salgado, 200420
(right int. jug. vein)
127 0%
Salgado, 200420
(left int. jug. vein)
44 9%Eur J Vasc Endovasc Surg Vol 32, October 2006additionally occur.24 Pelvic vein obstruction following
femoral vein catherisation frequently cause leg swell-
ing without a thigh access being fashioned, which, of
course, would markedly deteriorate with creation of
a functioning access.21,28
Swelling may cause difficulties in needling the ac-
cess with the risk of bleeding and haematoma. Skin
ulceration will further enhance the risk of infection
and access loss. Therefore, once swelling becomes
painful and incapacitating or causes needling or
skin problems, CVO should be treated.
Diagnostic Evaluation
Before treatment, exact delineation of the venous pa-
thology is essential. Colour-coded duplex-ultrasound
Fig. 1. Massive left arm edema in a 79 year old woman on
HD for diabetic nephropathy due to filiform subclavian
vein stenosis six months after creation of a brachiocephalic
fistula. Note the subcutaneous venous collaterals around
the left shoulder.
441Central Vein Obstructionis of limited value for this, because it fails to
adequately visualize either the innominate vein or
the proximal third of the subclavian vein.29 Although
phlebography is still the gold standard for diagnosis
of upper extremity venous stenoses and occlusions,30
MR phlebography should be considered, especially in
patients with residual renal function.31
Treatment
In HD access-associated CVO, a variety of surgical
and interventional, palliative and therapeutic, options
have to be discussed.
Access abandonment
The easiest surgical solution for access-associated CVO
is ligation of the access, which results in immediate re-
lief of symptoms.20,22,27,32 At the same time ligation is
the most frustrating option as the vascular pathology
causing the patient’s problem is not corrected and the
respective extremity is rendered unsuitable for further
access procedures. Access abandonment makes crea-
tion of a new permanent vascular access necessary, in
the other arm or in the leg, and should therefore be per-
formed onlywhen interventional or surgical therapy of
CVO is impossible or has failed.
Because CVO frequently occurs bilaterally,16 phle-
bography should be performed before the creation
Table 2. Results of PTA, stent placement and surgery, for central
venous obstructions in hemodialysis patients
Author, year
[reference]
# Primary
Patency
Secondary
Patency
1
year
2
years
1
years
2
years
PTA Glanz, 198738 30 35% 10% e e
Wisselink, 199339 15 36% 0% 86% 66%
Quinn, 199540 10 12% e 100% e
Money, 199541 26 7% e e e
Lumsden, 19975 17 17% e e e
Surowiec, 200442 35 43% 0% 80% 64%
PTA
þ Stent
Shoenfeld, 199443 19 68% e 93% e
Money, 199541 13 71% e e e
Quinn, 199540 8 11% e 78% e
Vorwerk, 199544 27 60% 60% e e
Mickley, 199724 14 70% 50% 100% 84%
Vesely, 199745 20 25% e 56% 22%
Haage, 199934 50 56% 28% e e
Chen, 200346 18 49% e 85% e
Aytekin, 200447 14 14% e 56% 33%
Surgery Wisselink, 199339 13 86% 66% e e
Gradman, 199452 9 88% 88% 100% 100%
Money, 199541 13 80% e e e
El-Sabrout, 199953 9 88% 88% 100% 100%
Haug, 199954 6 100% 33% 100% 100%
Mickley, 200155 6 83% 67% 100% 71%of a new access in another extremity. It is also advis-
able to create the new access and allow its maturation
before ligating the old one to avoid the further use of
a temporary catheter.
Fig. 2. a. Approximately 50% narrowing of left innominate
vein following subclavian vein catheterization for HD access
in a 68 year old woman undergoing HD for diabetic ne-
phropathy. Note the pacemaker wire inserted through right
internal jugular vein two years earlier, which is not causing
innominate or vena caval obstruction. b. Three months after
creation of a radio-cephalic AV fistula on her left arm, mas-
sive arm edema developed. There is now subtotal occlusion
of the left innominate vein. c. Successful PTA and stent
placement (Wallstent, 10 x 60 mm) resulted in immediate
relief of symptoms.Eur J Vasc Endovasc Surg Vol 32, October 2006
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Most patients present with long standing symptoms
of CVO so that thromboaspiration or thrombolysis
alone is unlikely to restore adequate venous patency.
However, in selected cases with evidence of fresh
thrombus causing total obstruction of a preexisting
tight venous stricture, thrombolysis may help to re-
establish the stenosed lumen and allow an additional
percutaneous transluminal angioplasty (PTA).33,34
PTA of CVO in HD patients has been reported since
the early 1980s.35,36,37 Because of frequent restenoses,
however, primary one-year patency of PTA alone was
less than 40% in most of the studies,5,38e42 (Table 2).
To reduce the number of re-interventions, several
groups have routinely performed stent placement
with each PTA procedure (Fig. 2aec), and most
reported improved primary patency rates when
compared to PTA alone,24,34,40,41,43e47(Table 2). A
more moderate use of stents (only for significant rest-
stenoses or elastic recoil after PTA, and for early or
frequent re-stenoses) has been practiced by otherEur J Vasc Endovasc Surg Vol 32, October 2006investigators48,49with satisfying results. The use of cov-
ered stents or endovascular brachytherapy following
stent placement does not enhance patency rates.50,51
Surgical reconstruction
As far as can be deduced from the few reports in the
literature,39,41,52e55 the results of surgical reconstruc-
tion of mediastinal veins in HD patients are better
than those of interventional radiology with primary
patency rates of 80% to 90% at one year. These
procedures, however, always mean major surgery.
Patch angioplasty of a subclavian or innominate
vein or orthotopic bypass surgery52,54,55 require cla-
vicular division or sternotomy (and general anesthe-
sia) (Fig. 3aed) and are associated with high rates of
postoperative morbidity and mortality. Extra-
anatomical bypass (such as axillary-to-internal jugular
vein39,41,55) is less distressing to the patient but this
results in the loss of another central vein for further
access.Fig. 3. a. Massive left arm and breast swelling two years after creation of a left brachio-cephalic AV fistula for HD in
a 59 year old woman with chronic glomerulonephritis. Note the extensive thoracic wall collaterals indicating bilateral
CVO. b and c. Bilateral arm phlebography demonstrating complete occlusion of both innominate veins. The central superior
vena cava is patent. The patient had had multiple central vein catheters for HD access and during intensive care treatment
five years ago for peritonitis following perforated diverticulitis. d. Graft interposition between central cephalic and superior
cava (ePTFE 12 mm with external ring support) through a median sternotomy.
443Central Vein ObstructionLast resort procedures
When the central venous drainage of all four extrem-
ities is compromised, construction or maintenance
of AV access can be difficult or impossible. In low
risk patients fit for median sternotomy, a subclavian
artery-to-right atrial appendix bridge graft56 can be
constructed, or an axillary vein-to-right atrial bypass53
be performed. In patients unfit for major surgery,
fashioning an arterio-arterial loop graft57,58 can be
considered as an alternative to the insertion of a trans-
lumbar, transhepatic or transthoracic, cuffed tunneled
catheter.59e61
Summary
 The main cause of central venous obstruction in
haemodialysis patients is prolonged or repeated
catheterization for dialysis access.
 Most frequent complaints are disabling swelling
and pain, sometimes combined with venous
ulceration.
 Access ligation brings immediate relief of com-
plaints, but makes creation of another permanent
access necessary.
 Surgical reconstruction of central veins has excel-
lent long-term results, but is associated with
significant morbidity and mortality.
 For the multimorbid hemodialysis patient, inter-
ventional treatment means a less distressing alter-
native with low acute complication rates and
tolerable long-term results.
 The role of stent implantation (during every PTA
or for selected indications) still remains to be
defined.
 Arterio-arterial loop grafts can be used as a last
resort access before translumbar, transhepatic or
transthoracic, insertion of cuffed tunneled catheters.
References
1 PISONI RL, YOUNG EW, DYKSTRA DM, GREENWOOD RN, HECKING E,
GILLESPIE B et al. Vascular access use in Europe and the United
States: results from the DOPPS. Kidney Int 2002;61:305e316.
2 RAYNER HC, BESARAB A, BROWN WW, DISNEYA, SAITO A, PISONI RL.
Vascular access results from the Dialysis Outcomes and Practice
Patterns Study (DOPPS): performance against Kidney Disease
Outcomes Quality Initiative (K/DOPQI) Clinical Practice Guide-
lines. Am J Kidney Dis 2004;44(Suppl. 2):S22eS26.
3 CHEMLA ES, KORRAKUTI L, MAKANJUOLA D, CHANG AR. Vascular
Access in hemodialysis patients with central venous obstruction
or stenosis: one center’s experience.AnnVascSurg2005;19:692e698.
4 MACRAE JM, AHMED A, JOHNSON N, LEVIN A, KIAII M. Central vein
stenosis: a common problem in patients on hemodialysis. ASAIO
J 2005;51:77e81.
5 LUMSDEN AB, MACDONALD MJ, ISIKLAR H, MARTIN LG, KIKERI D,
HARKER LA et al. Central venous stenosis in the hemodialysispatient: incidence and efficacy of endovascular treatment.
Cardiovasc Surg 1997;5:504e509.
6 BASILE C, GIORDANO R, MONTANARO A, LOMONTE C, CHIARULLI G.
Bilateral venous thoracic outlet syndrome in a haemodialysis
patient with long-standing body building activities. Nephrol
Dial Transplant 2001;16:639e645.
7 OGUZKURT L, TERCAN F, YILDIRIM S, TORUN D. Central venous
stenosis in haemodialysis patients without a previous history
of catheter placement. Eur J Radiol 2005;55:237e242.
8 ITKIN M, KRAUS MJ, TREROTOLA SO. Extrinsic compression of the
left innominate vein in hemodialysis patients. J Vasc Interv Radiol
2004;15:51e56.
9 CHUANG CL, TARNG DC, YANG WC, HUANG TP. An occult cause of
arteriovenous access failure: central vein stenosis from perma-
nent pacemaker wire. Report of three cases and review of the
literature. Am J Nephrol 2001;21:406e409.
10 STONE WJ, WALL MN, POWERS TA. Massive upper extremity
edema with arteriovenous fistula for hemodialysis. A com-
plication of previous pacemaker insertion. Nephron 1982;31:
184e186.
11 VANHERWEGHEM JL, YASSINE T, GOLDMAN M, VANDENBOSCH G,
DELCOUR C, STRUYVEN J et al. Subclavian vein thrombosis: a
frequent complication of subclavian vein cannulation for hemo-
dialysis. Clin Nephrol 1986;26:235e238.
12 SPINOWITZ BS, GALLER M, GOLDEN RA, PASCOFF JA, SCHECHTER L,
HELD B et al. Subclavian vein stenosis as a complication of sub-
clavian catheterization for hemodialysis. Arch Intern Med 1987;
157:305e307.
13 BARRETT N, SPENCER S, MCIVOR J, BROWN EA. Subclavian stenosis:
a major complication of subclavian dialysis catheters. Nephrol
Dial Transplant 1988;3:423e425.
14 SCHWAB SJ, QUARLES D, MIDDLETON JP, COHAN RH, SAEED M,
DENNIS VW. Hemodialysis-associated subclavian vein stenosis.
Kidney Int 1988;33:1156e1159.
15 WANSCHER M, FRIFELT JJ, SMITH-SEVERTSEN C, ANDERSEN AP,
RASMUSSEN AD, SANCHEZ GARCIA R et al. Thrombosis caused by
polyurethane double-lumen subclavian superior vena cava cath-
eter and hemodialysis. Crit Care Med 1988;16:624e628.
16 CIMOCHOWSKI GE, WORLEY E, RUTHERFORD WE, SARTAIN J, BLODIN J,
HARTER H. Superiority of the internal jugular over the subclavian
access for temporary dialysis. Nephron 1990;54:154e161.
17 SCHILLINGER F, SCHILLINGER D, MONTAGNAC R, MILCENT T. Post cath-
eterisation vein stenosis in haemodialysis: comparative angio-
graphic study of 50 subclavian and 50 internal jugular
accesses. Nephrol Dial Transplant 1991;6:722e724.
18 SURRATT RS, PICUS D, HICKS ME, DARCY MD, KLEINHOFFER M,
JENDRISACK M. The importance of preoperative evaluation of the
subclavian vein in dialysis access planning. Am J Roentgenol
1991;156:623e625.
19 HERNA´NDEZ D, DI´AZ F, SURIA S, MACHADO M, LORENZO V, LOSADA M
et al. Subclavian catheter-related infection is a major risk for
the late development of subclavian vein stenosis. Nephrol Dial
Transplant 1993;8:227e230.
20 SALGADO OJ, URDANETA B, COLMENARES B, GARCI´A R, FLORES C.
Right versus left internal jugular vein catheterization for hemo-
dialysis: complications and impact on ipsilateral access creation.
Artif Organs 2004;28:728e733.
21 WEYDE W, BADOKOWSKI R, KRAJEWSKA M, PENAR J, MORON K,
KLINGER M. Femoral and iliac vein stenoses after prolonged fem-
oral vein catheter insertion. Nephrol Dial Transplant 2004;19:
1618e1621.
22 CLARK DD, ALBINA JE, CHAZAN JA. Subclavian vein stenosis and
thrombosis: a potential serious complication in chronic hemo-
dialysis patients. Am J Kidney Dis 1990;15:265e268.
23 JEAN G, VANEL T, CHAZOT C, CHARRA B, TERRAT JC, HUROT JM. Pre´v-
alence des ste´noses et thromboses des veines centrales chez le
he´modialyse´s apre`s un cathe´ter jugulaire tunnelise´. Nephrologie
2001;22:501e504.
24 MICKLEY V, GO¨RICH J, RILINGER N, STORCK M, ABENDROTH D. Stenting
of central venous stenoses in hemodialysis patients: long-term
results. Kidney Int 1997;51:277e280.Eur J Vasc Endovasc Surg Vol 32, October 2006
444 V. Mickley25 KOOTSTRA G, SLOOF MJ, MEIJER S, IEGZESS AM. Venous hyperten-
sion of the hand caused by subcutaneous arteriovenous fistulae
established for hemodialysis. Arch Chir Neerl 1979;31:43e47.
26 IRVINE C, HOLT P. Hand venous hypertension complicating
arterio-venous fistula construction for haemodialysis. Clin Exp
Dermatol 1989;14:289e290.
27 HWANG SM, LEE SH, AHN SK. Pincer nail deformity and
pseudo-Kaposi’s sarcoma: complications of an artificial arte-
riovenous fistula for haemodialysis. Br J Dermatol 1999;141:
1129e1132.
28 HEGARTY J, PICTON M, CHALMERS N, KALRA PA. Iliac vein stenosis
secondary to femoral vein catheter placement. Nephrol Dial
Transplant 2001;16:1520e1521.
29 HAIRE WD, LYNCH TG, LIEBERMAN RP, LUND GB, EDNEY JA. Utility
of duplex ultrasound in the diagnosis of asymptomatic catheter-
induced subclavian vein thrombosis. J Ultrasound Med 1991;10:
493e496.
30 PORTER JM, MONETA GL. Reporting standards in venous disease:
an update. J Vasc Surg 1995;21:635e645.
31 HAAGE P, KRINGS T, SCHMITZ-RODE T. Non-traumatic vascular
emergencies: Imaging and intervention in acute venous occlu-
sion. Eur Radiol 2002;12:2627e2643.
32 OKADOME K, KOMORI K, FUKUMITSU T, SUGIMACHI K. The potential
risk for subclavian vein occlusion in patients on haemodialysis.
Eur J Vasc Surg 1992;6:602e606.
33 NEWMAN GE, SAEED M, HIMMELSTEIN S, COHAN RH, SCHWAB SJ.
Total central vein obstruction: resolution with angioplasty and
fibrinolysis. Kidney Int 1991;39:761e764.
34 HAAGE P, VORWERK D, PIROTH W, SCHUERMANN K, GUENTHER RW.
Treatment of hemodialysis-related central venous stenosis or oc-
clusion: Results of primary Wallstent placement and follow-up
in 50 patients. Radiology 1999;212:175e180.
35 GLANZ S, GORDON DH, BUTT KMH, HONG J, ADAMSON R,
SCLAFANI SJA. Dialysis access fistulas: Treatment of stenoses by
transluminal angioplasty. Radiology 1984;152:637e642.
36 INGRAM TL, REID SH, TISNADO J, CHO SR, POSNER MP. Percu-
taneous transluminal angioplasty of brachiocephalic vein
stenoses in patients with dialysis shunts. Radiology 1988;
166:45e47.
37 STALTER KA, STEVENS GF, STERLING WA. Late stenosis of the sub-
clavian vein after hemodialysis catheter injury. Surgery 1986;
100:924e927.
38 GLANZ S, GORDON DH, BUTT KMH, HONG J, LIPKOWITZ GS. The role
of percutaneous angioplasty in the management of chronic
hemodialysis fistulas. Ann Surg 1987;206:777e781.
39 WISSELINK W, MONEY SR, BECKER MO, RICE KL, RAMEE SR,
WHITE CJ et al. Comparison of operative reconstruction and
percutaneous balloon dilatation for central venous obstruction.
Am J Surg 1993;166:200e205.
40 QUINN SF, SCHUMAN ES, DEMLOW TA, STANDAGE BA, RAGSDALE LW,
GREEN GS et al. Percutaneous transluminal angioplasty versus
endovascular stent placement in the treatment of venous steno-
ses in patients undergoing hemodialysis: intermediate results.
J Vasc Interv Radiol 1995;6:851e855.
41 MONEY S, BHATIA D, DAHARAMSY S, MULINGTAPANG R, SHAW D,
RAMEE S. Comparison of surgical by-pass, percutaneous balloon
dilatation (PTA) and PTA with stent placement in the treatment
of central venous occlusion in the dialysis patient. One year
follow-up (Abstract). Int Angiol 1995;14:176.
42 SUROWIEC SM, FEGLEY AJ, TANSKI WJ, SIVAMURTHY N, ILLIG KA,
LEE DE et al. Endovascular management of central venous steno-
ses in the hemodialysis patient: results of percutaneous therapy.
Vasc Endovasc Surg 2004;38:349e354.Eur J Vasc Endovasc Surg Vol 32, October 200643 SHOENFELD R, HERMANS H, NOVICK A, BRENER B, CORDERO P,
EISENBUD D et al. Stenting of proximal venous obstructions
to maintain hemodialysis access. J Vasc Surg 1994;19:532e539.
44 VORWERK D, GUENTHER RW, MANN H, BOHNDORF K, KEULERS P,
ALZEN G et al. Venous stenoses and occlusions in hemodialysis
shunts: follow-up results of stent placement in 65 patients.
Radiology 1995;195:140e146.
45 VESELY TM, HOVSEPIAN DM, PILGRAM TK, COYNE DW, SHENOY S.
Upper extremity central venous obstruction in hemodialysis
patients: treatment with Wallstents. Radiology 1997;204:343e348.
46 CHEN CY, LIANG HL, PAN HB, CHUNG HM, CHEN WL, FANG HC
et al. Metallic stenting for treatment of central venous obstruc-
tion in hemodialysis patients. J Chin Med Assoc 2003;66:166e172.
47 AYTEKIN C, BOYVAT F, YAGMURDUR MC, MORAY G, HABERAL M. En-
dovascular stent placement in the treatment of upper extremity
central venous obstruction in hemodialysis patients. Eur J Radiol
2004;49:81e85.
48 MASˇKOVA´ J, KOMA´RKOVA´ J, KIVA´NEK J, DANESˇ J, SLAVI´KOVA´ M. Endo-
vascular treatment of central vein stenoses and occlusions in
hemodialysis patients. Cardiovasc Intervent Radiol 2003;26:27e30.
49 SPROUSE LR, LESAR CJ, MEIER GH, PARENT FN, DEMASI RJ, GAYLE RG
et al. Percutaneous treatment of symptomatic central venous ste-
nosis. J Vasc Surg 2004;39:578e582.
50 FARBER A, BARBER MM, GRUNERT JH, GMELIN E. Access-related
venous stenoses and occlusions: treatment with percutaneous
transluminal angioplasty and Dacron-covered stents. Cardiovasc
Intervent Radiol 1999;22:214e218.
51 KWOK PC, WONG KM, NGAN RK, CHAN SC, WONG WK, WONG KY
et al. Prevention of recurrent central venous stenosis using endo-
vascular irradiation following stent placement in hemodialysis
patients. Cardiovasc Intervent Radiol 2001;24:400e406.
52 GRADMAN WS, BRESSMAN P, SERNAQUE JD. Subclavian vein repair in
patients with an ipsilateral arteriovenous fistula. Ann Vasc Surg
1994;8:549e556.
53 EL-SABROUT RA, DUNCAN JM. Right atrial bypass grafting for cen-
tral venous obstruction associated with dialysis access: Another
treatment option. J Vasc Surg 1999;29:472e478.
54 HAUG M, POPESCU M, VONDERBANK E, KRU¨GER G. Die Rekonstruk-
tion mediastinaler Venen beim gleichseitigen Dialyseshunt.
Zentralbl Chir 1999;124:2e6.
55 MICKLEY V. Stent oder Bypass? Behandlungsergebnisse zentralve-
no¨ser Obstruktionen. Zentralbl Chir 2001;126:445e449.
56 MICKLEY V. Subclavian artery to right atrium haemodialysis
bridge graft for superior vena caval occlusion. Nephrol Dial
Transplant 1996;11:1361e1362.
57 BU¨NGER CM, KRO¨GER J, KOCK L, HENNING A, KLAR E, SCHARECK W.
Axillary-axillary interarterial chest loop conduit as an alternative
for chronic hemodialysis access. J Vasc Surg 2005;42:290e295.
58 ZANOW J, KRU¨GER U, PETZOLD M, PETZOLD K, MILLER H, SCHOLZ H.
Arterioarterial prosthetic loop: A new approach for hemodia-
lysis access. J Vasc Surg 2005;41:1007e1012.
59 KINNEY TB. Translumbar high inferior vena cava access place-
ment in patients with thrombosed inferior vena cava filters.
J Vasc Interv Radiol 2003;14:1563e1567.
60 SMITH TP, RYAN JM, REDDAN DM. Transhepatic catheter access for
hemodialysis. Radiology 2004;232:246e251.
61 WELLONS ED, MATSUURA J, LAI KM, LEVITT A, ROSENTHAL D. Trans-
thoracic cuffed hemodialysis catheters: a method for difficult
hemodialysis access. J Vasc Surg 2005;42:286e289.
Accepted 26 April 2006
Available online 9 June 2006
